Search

In Stock

Buy Radicut (edaravone) Online

DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction

MANUFACTURER: Mitsubishi Tanabe Pharma Co., Ltd.

USAGE: Intravenous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Health Canada

Pharmaceuticals and Medical Devices Agency (PMDA)

Radicut, also known as Edaravone, is a prescription medication used in the treatment of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. This medication has garnered attention for its potential to slow down the progression of ALS, offering new hope to individuals living with this devastating condition.

$944.97

Clear
Compare

Radicut (Edaravone): A Comprehensive Overview

Radicut, also known as Edaravone, is a prescription medication used in the treatment of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. This medication has garnered attention for its potential to slow down the progression of ALS, offering new hope to individuals living with this devastating condition.

In this comprehensive description of Radicut (Edaravone), we will explore its mechanism of action, indications, dosing, effectiveness, side effects, precautions, and more:

1. Drug Class and Mechanism of Action: Radicut (Edaravone) is classified as a free radical scavenger. Its precise mechanism of action in ALS treatment is not fully understood, but it is thought to work by reducing oxidative stress and inflammation, which are believed to contribute to the death of motor neurons in ALS patients. By decreasing the damage caused by free radicals, Radicut aims to slow the progression of the disease.

2. Indications: Radicut (Edaravone) is indicated for the treatment of ALS in adults. ALS is a rare and debilitating condition characterized by the gradual degeneration of motor neurons, leading to muscle weakness, loss of motor function, and, ultimately, paralysis. Edaravone is used to slow down the progression of ALS and improve the patient’s quality of life.

3. Dosage and Administration: Radicut (Edaravone) is administered intravenously (IV) by a healthcare professional. The typical dosage regimen involves a daily infusion for 10 to 14 days, followed by a 14-day drug-free period. This cycle is repeated for a total of six cycles, after which the treatment plan may be reassessed based on the patient’s response.

4. Effectiveness: Clinical trials and real-world experience have shown that Radicut (Edaravone) can slow down the progression of ALS in some patients. While it may not reverse the damage already done, it can help extend the period of functional independence and improve the patient’s overall quality of life. The extent of benefit varies among individuals.

5. Side Effects: Common side effects of Radicut (Edaravone) may include bruising or redness at the infusion site, headache, and difficulty walking. Some patients may also experience respiratory problems or skin reactions. It’s important to report any unusual or severe side effects to the healthcare provider.

6. Precautions and Monitoring: Before starting Radicut (Edaravone) treatment, the healthcare provider will perform a thorough evaluation to assess its suitability for the patient. Regular monitoring by healthcare professionals is essential during treatment to detect and manage potential side effects. Patients should also inform their healthcare provider of any underlying health conditions, current medications, or allergies.

7. Cost and Insurance Coverage: As a prescription medication, the cost of Radicut (Edaravone) can vary depending on your location and insurance coverage. It is important to check with your insurance provider and explore available financial assistance programs to help manage the cost, as ALS treatment can be expensive.

8. Duration of Treatment: The duration of Radicut (Edaravone) treatment typically involves six cycles, as mentioned earlier. However, the need for continued treatment may be reassessed based on the patient’s condition and response to therapy. ALS treatment often involves a multidisciplinary approach, including physical and occupational therapy, nutrition, and respiratory support, in addition to medication.

9. Special Populations: The use of Radicut (Edaravone) during pregnancy and breastfeeding should be discussed with a healthcare provider, as its effects on the developing fetus or infant are not well-studied. Women of childbearing age should discuss family planning and contraception options with their healthcare provider if considering Edaravone treatment.

10. Conclusion: Radicut (Edaravone) is a valuable addition to the treatment options available for individuals living with ALS. Its ability to reduce oxidative stress and inflammation offers the potential to slow down the progression of this devastating neurodegenerative disease. While Radicut can provide meaningful benefits, it should be closely monitored by a healthcare provider due to potential side effects, and its suitability should be thoroughly discussed to determine the best treatment approach for the individual’s needs. ALS treatment is typically a collaborative effort involving various healthcare professionals to address the comprehensive needs of the patient.

Package

10 bags of 30 mg/100 mL, 10 vials of 30 mg/20 mL

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Radicut (edaravone) Online

$944.97
(0 Reviews)
DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction MANUFACTURER: Mitsubishi Tanabe Pharma Co., Ltd. USAGE: Intravenous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Radicut, also known as Edaravone, is a prescription medication used in the treatment of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. This medication has garnered attention for its potential to slow down the progression of ALS, offering new hope to individuals living with this devastating condition.

Buy Aimovig (erenumab) Online

From $440.35
(0 Reviews)
DISEASE INDICATIONS: Migraine MANUFACTURER: Amgen Inc. / Novartis Pharmaceuticals Corporation USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Swissmedic (CH) Medsafe (NZ) Aimovig (erenumab) is a prescription medication used to treat certain types of migraine headaches in adults.

Buy Rilutek (riluzole) Online

$211.07
(0 Reviews)
DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS) MANUFACTURER: Sanofi - Aventis Groupe USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Medicines & Healthcare products Regulatory Agency (MHRA) Medsafe (NZ) Rilutek, also known by its generic name Riluzole, is a medication that has brought hope and relief to countless individuals facing the debilitating effects of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

Buy Glentek (riluzole) Online

(0 Reviews)
DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS) MANUFACTURER: Glentek USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Therapeutic Goods Administration (TGA) Medicines & Healthcare products Regulatory Agency (MHRA) The Medicines Evaluation Board (MEB) Glentek is a medication belonging to the class of drugs known as glutamate inhibitors. It is primarily used in the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

Buy Ocrevus (ocrelizumab) Online

$5,892.70
(0 Reviews)
DISEASE INDICATIONS: Multiple Sclerosis MANUFACTURER: Roche Registration Limited USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Medsafe (NZ) Ocrevus (ocrelizumab) is a groundbreaking prescription medication used in the treatment of multiple sclerosis (MS). It is a disease-modifying therapy (DMT) designed to alter the course of the disease by suppressing the immune system's abnormal response that leads to damage in the central nervous system. Since its approval, Ocrevus has played a significant role in the management of MS, offering new hope to patients by effectively targeting both relapsing forms and primary progressive forms of the disease.

Buy Ajovy (fremanezumab-vfrm) Online

$522.84
(0 Reviews)
DISEASE INDICATIONS: Migraine MANUFACTURER: Teva Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Ajovy (fremanezumab-vfrm) is a prescription medication used for the preventive treatment of migraine headaches in adults.

Buy Spinraza (Nusinersen) Online

(0 Reviews)
DISEASE INDICATIONS: Spinal Muscular Atrophy MANUFACTURER: Biogen Idec Ltd USAGE: Intrathecal Injection MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Medsafe (NZ) Spinraza, also known by its generic name Nusinersen, is a groundbreaking medication that has transformed the landscape of treatment for Spinal Muscular Atrophy (SMA), a rare genetic disorder characterized by the progressive degeneration of motor neurons in the spinal cord.

Back to Top
Product has been added to your cart